Company profile for Sera Prognostics

Sera Prognostics

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

pharmacompass-2-m-2025-11-03

Contact Supplier

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

6 News #PharmaBuzz

media
6 News #PharmaBuzz

REF. STANDARDS & IMPURITIES

1 Others

otherProducts
1 Others

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sera Prognostics was founded to develop diagnostic tests for the early prediction of a woman’s individualized risk of premature birth, preeclampsia, and other pregnancy complications. Sera’s tests are designed to give women and their physicians the power and time to make a difference in maternal and newborn health with individualized treatment and care plans. The company has completed Its landmark Proteomic Assessment of P...

Sera Prognostics was founded to develop diagnostic tests for the early prediction of a woman’s individualized risk of premature birth, preeclampsia, and other pregnancy complications. Sera’s tests are designed to give women and their physicians the power and time to make a difference in maternal and newborn health with individualized treatment and care plans. The company has completed Its landmark Proteomic Assessment of Preterm Risk (PAPR) clinical study that clinically validated the PreTRM test as highly predictive of preterm birth early in pregnancy.

Tides AsiaTides Asia

Not Confirmed

Not Confirmed

24-26 February, 2026

Tokyo, Japan
Global ChemShowGlobal ChemShow

Not Confirmed

Not Confirmed

19-20 December, 2025

Bombay Exhibition Centre, Mumbai
BIO Partnering at JPMBIO Partnering at JPM

Not Confirmed

Not Confirmed

12-15 January, 2026

San Francisco Marriott Marquis, California

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

United_States_of_America Flag

Country

Country

U.S.A

Address

Address

Address: 2749 East Parleys Way, Suite 200 Salt Lake City, UT 84109

Telephone

Telephone

801-990-0520

Email

enquiries@pharmacompass.com

Client Website

Website

https://seraprognostics.com/

Linkedin

https://in.linkedin.com/company/sera-prognostics

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Sera Prognostics Reports Third Quarter 2025 Financial Results

13 Nov 2025

// PR NEWSWIRE BIO

Sera Prognostics Report Q4 2024 Financial Result

19 Mar 2025

// PR NEWSWIRE

Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield

15 May 2023

// PR NEWSWIRE

Sera Prognostics Reports Fourth Quarter 2022 Financial Results

22 Mar 2023

// PR NEWSWIRE

SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX

15 Dec 2021

// PRNEWSWIRE

Sera Prognostics Announces Publication of the Clinical Validation of PreTRM®

03 Nov 2021

// PRNEWSWIRE

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Others

Only 10 entries up to this point, click to access all

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Market Place

Home

Menu

Post Enquiry

Market Place

Search